Table 3.
Overview of influential metabolites discriminating ulcerative colitis and Crohn’s disease patients
| Comparison UC - CD subjects at metabolites |
Baseline |
6 mo |
12 mo |
|||
| VIP | r | VIP | r | VIP | r | |
| DCA | 1.6 | 0.5 | 1.4 | 0.5 | 0.8 | 0.2 |
| 7-ketoLCA | 1.1 | 0.3 | 1.2 | 0.4 | 1.8 | 0.5 |
| Beta-UCA | 0.3 | 0.1 | 2.0 | 0.7 | 1.0 | 0.3 |
UC: Ulcerative colitis; CD: Crohn’s disease; DCA: Deoxycholic acid; 7_KetoLCA: 7-ketolithocholic acid; bUCA: Beta-ursocholic acid.